Tami Martin, R.N.
2017
In 2017, Tami Martin, R.N. earned a total compensation of $671K as Senior Vice President, Regulatory Affairs at Supernus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $84,413 |
|---|---|
| Option Awards | $244,719 |
| Salary | $298,700 |
| Other | $43,125 |
| Total | $670,957 |
RN received $298.7K in salary, accounting for 45% of the total pay in 2017.
RN also received $84.4K in non-equity incentive plan, $244.7K in option awards and $43.1K in other compensation.
Rankings
In 2017, Tami Martin, R.N.'s compensation ranked 10,792nd out of 14,666 executives tracked by ExecPay. In other words, RN earned more than 26.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,792 out of 14,666 | 26th |
Division Manufacturing | 4,207 out of 5,772 | 27th |
Major group Chemicals And Allied Products | 1,508 out of 2,075 | 27th |
Industry group Drugs | 1,233 out of 1,731 | 29th |
Industry Pharmaceutical Preparations | 960 out of 1,333 | 28th |
Source: SEC filing on April 24, 2020.
RN's colleagues
We found five more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2017.
2017
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
2017
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
2017
Victor Vaughn
Supernus Pharmaceuticals
Senior Vice President of Sales and Marketing
2017
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
2017
Padmanabh Bhatt
Supernus Pharmaceuticals